ArticleOphthalmology science2026
Retinal Arterial Wall Reflectivity and Incident Cardiovascular Disease.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine whether retinal arterial wall reflectivity is associated with future cardiovascular disease (CVD) in a large community-based Japanese cohort. Design: Community-based cohort study. Participants: A total of 6264 adults from the Nagahama Study (baseline 2012-2016) without a history of CVD. Methods: Retinal arterial wall reflectivity was measured on peripapillary OCT images at baseline. Participants were followed for approximately 7 years, and incident CVD events, including stroke and coronary artery disease (CAD), were identified through medical records. Associations were evaluated using Fine-Gray competing risk models and expressed as subdistribution hazard ratios (SHRs). Retinal arterial caliber was included in multivariable analyses. Main Outcome Measures: Incident CVD events, including stroke and CAD. Results: During a mean follow-up of 6.7 years, 125 incident CVD events occurred. In the full cohort, retinal arterial wall reflectivity was not independently associated with CVD (SHR per 10 arbitrary units, 1.026; 95% confidence interval [CI], 0.920-1.145). A continuous age-by-reflectivity interaction was observed ( Conclusions: Retinal arterial wall reflectivity was not independently associated with incident CVD in the full cohort. Post hoc exploratory analyses among participants younger than 70 years suggested possible modest associations with CVD, particularly stroke-related outcomes. These findings suggest that retinal arterial wall reflectivity may reflect subclinical vascular alterations, but require external validation. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.